Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
- Status
- UNKNOWN
- Phase
- NA
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Family History App in Personalized Medicine
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DNX-2440 for Resectable Colorectal Liver Metastasis
- Status
- SUSPENDED
- Phase
- PHASE1
Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
CMP-001 in Combination With Nivolumab in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CMP-001 in Combination With Nivolumab Compared to Nivolumab Monotherapy in Subjects With Advanced Melanoma
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Early Complications After Axillary and Inguinal Lymph Node Dissection in Stage III Melanoma Patients
- Status
- COMPLETED
- Phase
- NA
Effectiveness and Safety of Dabrafenib in Combination With Trametinib as Adjuvant Treatment for Chinese Patients With Stage III BRAF V600 Mutation-positive Melanoma After Complete Resection
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Feasibility of IV Tc-99m-tilmanocept for Imaging of M2-like TAMs in Metastatic Melanoma
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Evolution of Metabolic and Immune Dysfunction in In-transit Melanoma
- Status
- RECRUITING
- Phase
- N/A
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Safety and Efficacy in Participants With Metastatic BRAF-mutant Melanoma Treated With Encorafenib With and Without Binimetinib in Combination With Nivolumab and Low-dose Ipilimuma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2
Risk Factors of Immune-ChEckpoint Inhibitors MEdiated Liver, Gastrointestinal, Endocrine and Skin Toxicity
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Study of INCB086550 in Select Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE2